The Persistent Clinical Problem of VTE in the Post-Acute, Medically Ill Population

Released On
November 19, 2021

Expires On
November 19, 2022

Media Type

Completion Time
15 minutes

Cardiology, Geriatric Medicine, Hematology-Oncology, Hospitalist, Pharmacy, Primary Care

Acute Coronary Syndrome, Acute Heart Failure, Acute Myocardial Infarction, Bleeding Disorders, Cardiovascular Disease, Geriatric Medicine, Heart Disease, Stroke

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Paradigm Medical Communications, LLC and Educational Review Systems, Inc.

This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Credit Available

  • Physicians — maximum of 0.25 AMA PRA Category 1 Credit
  • Pharmacists — 0.25 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity has been designed to address the educational needs of cardiologists, hospitalists, interventional cardiologists, internists, primary care physicians (PCPs), clinical pharmacists, hematologists, and other clinicians who are involved or interested in the medical management of patients with venous thromboembolism (VTE) and/or at risk for VTE.

Program Overview

Faculty considers the risk factors for, and burden of, VTE in acutely ill medical patients, during the hospitalization and postdischarge periods.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify medically ill patients at risk for VTE who qualify for extended postdischarge prophylaxis according to available risk-stratification criteria


Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC (Chair)

Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Professor, The Merinoff Center for Patient-Oriented Research
Feinstein Institutes for Medical Research
System Director—Anticoagulation and Clinical Thrombosis Services
Northwell Health
New York, NY

Gregory Piazza, MD

Director, Vascular Medicine Section
Division of Cardiovascular Medicine
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Victor Tapson, MD, FCCP, FRCP

Professor of Medicine
Associate Director of Pulmonary Critical Care
Director of Venous Thromboembolism Research
Cedars-Sinai Medical Center
Los Angeles, CA

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Paradigm Medical Communications, LLC and Educational Review Systems, Inc. Paradigm Medical Communications, LLC is accredited by the ACCME to provide continuing medical education for physicians.


Physician Credit Designation

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation and Designation Statement

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 0.25 contact hour (0.025 CEU) submitted to CPE Monitor as early as 14 days after completion and no later than 60 days after completion. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-21-328-H01-P

This is a knowledge-based activity.

PA Continuing Education

PAs may claim a maximum of 0.25 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.


In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any financial relationships occurring over the past 24 months with ineligible companies whose products or services are associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts of interest have been mitigated.

Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC (Chair)
Advisor: Alexion Pharmaceuticals, Inc.
Consultant: Bayer Corporation; Boehringer Ingelheim Pharmaceuticals, Inc; Bristol-Myers Squibb Company; Janssen Pharmaceuticals, Inc.
Research Funding: Boehringer Ingelheim Pharmaceuticals, Inc; Janssen Pharmaceuticals, Inc.
Independent Contractor: The Antithrombotic Trials Leadership and Steering (ATLAS) Group

Gregory Piazza, MD
Research Funding: Amgen Inc; Bayer Corporation; Bristol-Myers Squibb-Pfizer Alliance; Boston Scientific Corporation; Janssen Pharmaceuticals, Inc; Portola Pharmaceuticals, Inc.

Victor Tapson, MD, FCCP, FRCP
Advisor: Bayer Corporation; Boston Scientific Corporation; Bristol-Myers Squibb Company; Inari Medical, Inc.; Janssen Pharmaceuticals, Inc; Penumbra, Inc.; Thrombolex
Consultant: Bayer Corporation; Boston Scientific Corporation; Janssen Pharmaceuticals, Inc.
Speaker’s Bureau: Janssen Pharmaceuticals, Inc.
Research Funding: Boston Scientific Corporation; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc; Janssen Pharmaceuticals, Inc.

Paradigm Medical Communications, LLC staff members have no relevant financial relationship(s) with ineligible companies to disclose.

Independent peer reviewer has no relevant financial relationship(s) with ineligible companies to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are mitigated through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Instructions for Participation and Credit

To receive a CE certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the preactivity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.


For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or

There is no fee required for participation in this activity.

Course Viewing Requirements

Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here:

Technical Support: If you have any technical problems or playback issues, email us at

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.


This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

© 2021 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.

Contact Information

If you have any questions or comments, please email us at